Wide Ranks

CVKD

Cadrenal Therapeutics, Inc.

14.15

Top Statistics
Market Cap 23 M Forward PE -3.31 Revenue Growth 0.00 %
Current Ratio 3.69 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.42 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 4 M Total Cash Per Share 3.95 Total Debt 2232
Total Debt To Equity 0.0650 Current Ratio 3.69 Book Value Per Share 3.09
All Measures
Short Ratio 80.00 % Message Board Id finmb_1793167154 Shares Short Prior Month 23891
Return On Equity -1.25 City Ponte Vedra Uuid ba078ec3-1bff-3797-99d9-a2e1a25e88f8
Previous Close 13.71 First Trade Date Epoch Utc 1 B Book Value 3.09
Total Debt 2232 Volume 32998 Price To Book 4.58
Last Split Date 1 B Fifty Two Week Low 5.40 Total Cash Per Share 3.95
Shares Short Previous Month Date 1 B Target Median Price 32.00 Max Age 86400
Recommendation Mean 1.50 Sand P52 Week Change 0.3133 Target Mean Price 35.67
Net Income To Common -7608159 Short Percent Of Float 0.0556 Implied Shares Outstanding 1 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 52350
Average Volume10days 52350 Total Cash 4 M Next Fiscal Year End 1 B
Held Percent Insiders 0.3406 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 13.71 Target Low Price 30.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 14.53 Open 14.43
Free Cashflow -3667666 State FL Dividend Yield 0.00 %
Return On Assets -0.7099 Time Zone Short Name EST Trailing Eps -6.73
Day Low 13.19 Address1 822 A1A North Shares Outstanding 1 M
Price Hint 2 Target High Price 45.00 Website https://www.cadrenal.com
52 Week Change 1.05 Average Volume 58456 Forward Eps -4.72
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 344.40 %
Last Split Factor 1:15 Regular Market Day High 14.43 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 0.0650 Fifty Two Week High 32.55
Day High 14.43 Shares Short 66017 Regular Market Open 14.43
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0398 Operating Cashflow -6261289 Currency USD
Time Zone Full Name America/New_York Market Cap 23 M Is_nasdaq_100 False
Zip 32082 Quote Type EQUITY Industry Biotechnology
Long Name Cadrenal Therapeutics, Inc. Regular Market Day Low 13.19 Held Percent Institutions 0.0474
Current Price 14.15 Address2 Suite 306 Enterprise To Ebitda -1.42
Financial Currency USD Current Ratio 3.69 Industry Disp Biotechnology
Number Of Analyst Opinions 3 Country United States Float Shares 687276
Two Hundred Day Average 9.41 Enterprise Value 11 M Forward PE -3.31
Regular Market Volume 32998 Ebitda -7943952 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company.

The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome.

Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.